Watchlist Price Alert

Aspire BioPharma Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.34

-0.02 (-5.29%)

At close: May 02, 2025, 3:59 PM

0.38

11.59%

After-hours: May 02, 2025, 05:56 PM EDT

Aspire BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Cash & Equivalents	3.63K	16.54K	19.6K	n/a	11.17K	280.00	125.2K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	20.14M	n/a	19.64M	20.02M
Other Long-Term Assets	n/a	-5.03M	n/a	n/a	-4.97M	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	65.58K	n/a	253.08K	420.94K
Total Current Assets	147.99K	184.04K	49.6K	65.58K	46.17K	253.36K	546.14K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	5.03M	5.01M	n/a	4.97M	n/a	n/a
Total Long-Term Assets	n/a	n/a	5.01M	20.14M	n/a	19.64M	20.02M
Total Assets	147.99K	184.04K	5.06M	20.2M	46.17K	19.89M	20.56M
Account Payables	310.22K	129.39K	161.53K	n/a	172.77K	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.27M	853.11K	445.41K	2M	360.64K	n/a	n/a
Other Current Liabilities	111.03K	3.13K	157.34K	633.95K	626.00	316.32K	284.36K
Total Current Liabilities	1.69M	985.63K	764.28K	2.63M	534.03K	316.32K	284.36K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	3.85M	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	3.85M	n/a	n/a	n/a	n/a
Total Liabilities	1.69M	985.63K	4.62M	2.63M	534.03K	316.32K	284.36K
Total Debt	1.27M	853.11K	445.41K	2M	360.64K	n/a	n/a
Common Stock	22K	221.66K	221.66K	20.14M	221.5K	19.64M	20.02M
Retained Earnings	-2.78M	-2.04M	-1.8M	-13.99M	-1.47M	-10.88M	-10.55M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-1.54M	-801.59K	442.04K	17.57M	-487.86K	19.58M	20.28M
Total Investments	n/a	n/a	n/a	20.14M	n/a	19.64M	20.02M